Valuation: InterCure Ltd.

Market Cap 200M 0 176M 167M 151M 284M 19.18B 288M 2B 769M 9.81B 751M 735M 31.44B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 336M 0 296M 281M 253M 478M 32.26B 484M 3.36B 1.29B 16.49B 1.26B 1.24B 52.87B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.82%
Yield 2024 *
-
Yield 2025 -
1 day+0.72%
1 week+0.66%
Current month+0.72%
1 month-1.40%
3 months-0.32%
6 months+40.22%
Current year+4.39%
1 week 1,584
Extreme 1584
1,700
1 month 1,569
Extreme 1569
1,748
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,783.5
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 2019-12-23
Director of Finance/CFO 47 2020-02-29
General Counsel - 2022-03-31
Director TitleAgeSince
Director/Board Member 50 2015-09-02
Director/Board Member 67 2014-12-13
Chairman 55 2025-02-12
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 Other

Chief Financial Officer

539,947 0.9874%
3/18/26 Other

Director

19,046 0.0348%
3/18/26 Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
+0.72%+0.66%-36.84%-45.48% 64.76M
-0.17%+1.29%+12.07%+23.62% 110B
+0.74%+1.73%+1.11%+74.26% 92.39B
+0.56%+1.06%+155.63%+845.79% 59.58B
+0.15%-4.41%-6.75%+50.03% 28.62B
-0.33%-1.67%+27.78%+92.42% 25.72B
-0.09%-0.41%+10.26%+54.18% 24.99B
-0.57%+0.09%-15.97%-6.32% 21.11B
+0.67%+3.13%+27.82%+288.94% 20.58B
-1.66%-4.47%-3.02%+33.22% 16.95B
Average +0.07%-0.28%+17.21%+141.07% 39.96B
Weighted average by Cap. +0.24%-0.07%+29.17%+178.61%

Financials

2024 2025
Net sales 239M 0 210M 199M 180M 339M 22.9B 343M 2.38B 918M 11.71B 897M 877M 37.53B 270M 0 238M 225M 204M 384M 25.91B 389M 2.7B 1.04B 13.24B 1.01B 992M 42.46B
Net income -67.8M -0 -59.7M -56.56M -51.07M -96.25M -6.5B -97.49M -677M -260M -3.32B -255M -249M -10.65B -35.71M -0 -31.45M -29.79M -26.9M -50.7M -3.42B -51.35M -356M -137M -1.75B -134M -131M -5.61B
Net Debt 133M 0 117M 111M 99.99M 188M 12.73B 191M 1.33B 510M 6.51B 498M 488M 20.86B 136M 0 120M 114M 103M 194M 13.07B 196M 1.36B 524M 6.68B 512M 501M 21.43B
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
26-10-01 ILA 1,689.00 +0.72% 608
26-09-30 ILA 1,677.00 +2.26% 3,385
26-09-29 ILA 1,640.00 +1.93% 2,113
26-09-28 ILA 1,609.00 -4.11% 4,975
26-09-24 ILA 1,678.00 -0.12% 3,541
  1. Stock Market
  2. Stocks
  3. INCR Stock